PO Box 9530
Department of Basic Pharmaceutical Sciences
West Virginia University
- Curriculum Vitae
- Download CV
- West Virginia University School of Pharmacy
- Pharmaceutical Sciences
Program 5: Sara Crile Allen and James Frederick Allen Lung Cancer (Emerging)
- PhD, Clarkson University, 1991
Ten Most Recent:
The aryl hydrocarbon receptor interacts with nuclear factor erythroid 2-related factor 2 to mediate induction of NAD(P)H:quinoneoxidoreductase 1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Wang L, He X, Szklarz GD, Bi Y, Rojanasakul Y, et al.
Archives of biochemistry and biophysics. 2013; 537(1):31-8. NIHMSID: HHSPA723354 PubMed [journal] PMID: 23800876 PMCID: PMC4597779
Human cytochrome P450 1A1 structure and utility in understanding drug and xenobiotic metabolism.
Walsh AA, Szklarz GD, Scott EE.
The Journal of biological chemistry. 2013; 288(18):12932-43.
PubMed [journal] PMID: 23508959 PMCID: PMC3642336
The effect of rural upbringing and education on the intent of health professional students to work in rural settings.
Trickett-Shockey AK, Wilson CS, Lander LR, Barretto GA, Szklarz GD, et al. Int. J. Med. Educ.. 2013; 4:18-25.
My Bibliography [journal]
Preferred binding orientations of phenacetin in CYP1A1 and CYP1A2 are associated with isoform-selective metabolism.
Huang Q, Deshmukh RS, Ericksen SS, Tu Y, Szklarz GD.
Drug metabolism and disposition: the biological fate of chemicals. 2012; 40(12):2324-31.
PubMed [journal] PMID: 22949628 PMCID: PMC3500547
Resveratrol inhibits paraquat-induced oxidative stress and fibrogenic response by activating the nuclear factor erythroid 2-related factor 2 pathway.
He X, Wang L, Szklarz G, Bi Y, Ma Q.
The Journal of pharmacology and experimental therapeutics. 2012; 342(1):81-90. NIHMSID: HHSPA744485 PubMed [journal] PMID: 22493042 PMCID: PMC4696400
Differential oxidation of two thiophene-containing regioisomers to reactive metabolites by cytochrome P450 2C9.
Rademacher PM, Woods CM, Huang Q, Szklarz GD, Nelson SD.
Chemical research in toxicology. 2012; 25(4):895-903. NIHMSID: NIHMS358462 PubMed [journal] PMID: 22329513 PMCID: PMC3339269
Significant increase in phenacetin oxidation on L382V substitution in human cytochrome P450 1A2.
Huang Q, Szklarz GD.
Drug metabolism and disposition: the biological fate of chemicals. 2010; 38(7):1039-45.PubMed [journal] PMID: 20335269 PMCID: PMC2908983
Application of molecular modeling for prediction of substrate specificity in cytochrome P450 1A2 mutants.
Tu Y, Deshmukh R, Sivaneri M, Szklarz GD.
Drug metabolism and disposition: the biological fate of chemicals. 2008; 36(11):2371-80. NIHMSID: NIHMS66090 PubMed [journal] PMID: 18703643 PMCID: PMC2574645
Regiospecificity of human cytochrome P450 1A1-mediated oxidations: the role of steric effects.
Ericksen SS, Szklarz GD.
Journal of biomolecular structure & dynamics. 2005; 23(3):243-56.PubMed [journal] PMID: 16218752
Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1: highly stereoselective formation of 17(R),18(S)-epoxyeicosatetraenoic acid.
Schwarz D, Kisselev P, Ericksen SS, Szklarz GD, Chernogolov A, et al.
Biochemical pharmacology. 2004; 67(8):1445-57. PubMed [journal] PMID: 15041462
Postdoctoral fellow, 1991-92, University of California, San Francisco, California
M.S. in Biology, 1981, Maria Curie-Sklodowska University, Lublin, Poland
Ph.D. in Chemistry, 1991, Clarkson University, Potsdam, New York
Post-doctoral Fellow, 1991-1992, Department of Pediatrics, University of California, San Francisco, CA
Research Associate, 1992-1995, Department of Pharmacology and Toxicology, University of Arizona, Tucson, AZ
Assistant Research Scientist, 1995-1997, Department of Pharmacology and Toxicology, University of Arizona, Tucson, AZ
Associate Research Scientist, 1998, Department of Pharmacology and Toxicology, University of Arizona, Tucson, AZ
Assistant Professor, August 1998-2004, Department of Basic Pharmaceutical Sciences, School of Pharmacy, West Virginia University, Morgantown, WV
Associate Professor, July 2004-present, Department of Basic Pharmaceutical Sciences, School of Pharmacy, West Virginia University, Morgantown, WV
Structure and function of cytochromes P450
Homology modeling of enzyme structure
Utilization of molecular modeling methods to study protein function
P450-mediated drug metabolism and carcinogenesis
My current research focuses on structure-function relationships of human cytochromes P450 1A1 and 1A2, which play a key role in the metabolic activation of chemical carcinogens and in the metabolism of drugs. The objective of this research is to elucidate the structural basis for the function of these enzymes using a combination of molecular modeling and experimental methods, such as heterologous expression, site-directed mutagenesis and biochemical assays. We apply molecular modeling methods, such as molecular dynamics, to predict product profiles and kinetic constants, as well as NMR techniques, which will help to characterize enzyme-substrate interactions in the active site.
This research lies at the interface between the application of the theory of computational chemistry and the utilization of experimental methods, such as NMR and molecular biology techniques, and has a potential for advancing our understanding of how enzymes activate or deactivate drugs and xenobiotics.
Molecular modeling , homology modeling of proteins
Heterologous expression of mammalian enzymes in E. coli
Protein purification and analysis - chromatography, SDS-PAGE, Western blots, etc.
Enzyme assays, enzyme kinetics - spectroscopic methods, HPLC
Molecular biology - gene cloning and site-directed mutagenesis
Structural basis for functional differences between human cytochromes P450 1A1 and 1A2, 1999- 2000 (WVU Senate Research Grant)
Active site model of cytochromes P450 1A1 and 1A2, 2000-2002 (NIH/NCI)
Structural determinants of P450 1A1 and 1A2 specificity. 2001-2006 (NIH/NCRR)
Cytochrome P450-reductase interactions in the P450 1A subfamily, 2006 (Bridge Grant, WVU HSC)
Cytochrome P450-reductase interactions in P450 1A subfamily, 2007-2010 (NIH/NIGMS)
Phar 731: Biopharmaceutics and Pharmacokinetics
Phar 779: Drugs Discovery and Development
Phar 780: Introduction to Molecular Modeling
Phar 781: Drug Metabolism
Member of Editorial Board of Drug Metabolism and Disposition
Workshop Presenter for Expanding Your Horizons in Math and Science Conferences organized by AWIS-WV
American Association of Colleges of Pharmacy
American Chemical Society
American Society for Pharmacology and Therapeutics
Association for Women in Science
International Society for the Study of Xenobiotics
Sara Crile Allen and James Frederick Allen Lung Cancer